← Leaderboards
David C Hess
Augusta University
$10,216,678
Attributed
$11,395,290
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2007–25$2.5M$1.9M$1.3M$625K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,395,290 · 10
By mechanism
R01$5,464,608 · 4
U01$2,874,965 · 2
RF1$1,565,442 · 1
R21$1,490,275 · 3
Top collaborators
- Krishnan M. Dhandapani3 shared
- Mohammad Badruzzaman Khan3 shared
Most similar at Augusta University
Same institution · by research overlap
- Krishnan M. Dhandapani$9,189,716
- Mohammad Badruzzaman Khan$589,306
Others in their field
Top investigators on “Stroke”
- Judith S Hochman · New York University School Of Medicine$100,533,713
- Joseph Paul Broderick · University Of Cincinnati$91,227,021
- Merit E Cudkowicz · Massachusetts General Hospital$58,780,575
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Marinella Temprosa · George Washington University$56,125,420
- Anne Christine Gelijns · Icahn School Of Medicine At Mount Sinai$53,611,126
Research focus
StrokeNeuroprotectionClinical TrialsCerebrovascular CirculationBrainBlood FlowBlood PressureLimb StructureIschemic StrokeStroke TherapyIschemic ConditioningAnimalsFda ApprovedPlasmaPre-ClinicalBilateralFunctional OutcomesCarotid StenosisHospitalsAcute StrokePharmaceutical PreparationsAcute-Amp-Activated Protein KinaseAmbulances
Grant awards (28)
Augusta SPAN 2$554,399
U01 · FY2025 · NS · contact PI
Targeting RBC dysfunction in VCID$521,814
R01 · FY2025 · NS · contact PI
Augusta SPAN 2$597,519
U01 · FY2024 · NS · contact PI
Targeting RBC dysfunction in VCID$521,814
R01 · FY2024 · NS · contact PI
Augusta SPAN 2$616,000
U01 · FY2023 · NS · contact PI
Rheoerythrocrine dysfunction in stroke and remote ischemic conditioning (REDS)$199,584
R01 · FY2023 · NS · contact PI
Rheoerythrocrine dysfunction in stroke and remote ischemic conditioning (REDS)$248,320
R01 · FY2022 · NS · contact PI
Targeting RBC dysfunction in VCID$1,565,442
RF1 · FY2021 · NS · contact PI
Remote Ischemic Conditioning: A collateral therapeutic and neuroprotectant$492,694
U01 · FY2021 · NS · contact PI
Rheoerythrocrine dysfunction in stroke and remote ischemic conditioning (REDS)$248,320
R01 · FY2021 · NS · contact PI
Remote Ischemic Conditioning: A collateral therapeutic and neuroprotectant$499,884
U01 · FY2020 · NS · contact PI
Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID Model$380,000
R01 · FY2020 · NS · contact PI
COVID-19 Neurological Georgia Cohort Study$308,000
R01 · FY2020 · NS · contact PI
Rheoerythrocrine dysfunction in stroke and remote ischemic conditioning (REDS)$306,366
R01 · FY2020 · NS · contact PI
Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID Model$380,000
R01 · FY2019 · NS · contact PI
Remote Ischemic Conditioning: A collateral therapeutic and neuroprotectant$114,469
U01 · FY2019 · NS · contact PI
Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID Model$380,000
R01 · FY2018 · NS · contact PI
Mechanisms of Chronic Remote Ischemic Conditioning Induced Cerebroprotection in a VCID Model$380,000
R01 · FY2017 · NS · contact PI
Remote ischemic conditioning for neuroprotection in vascular cognitive impairment$380,000
R21 · FY2016 · NS · contact PI
Remote ischemic conditioning for neuroprotection in vascular cognitive impairment$380,000
R21 · FY2015 · NS · contact PI
Remote Ischemic Conditioning:Translating Endogenous Neuroprotection in Embolic St$185,625
R21 · FY2014 · NS · contact PI
Remote Ischemic Conditioning:Translating Endogenous Neuroprotection in Embolic St$225,000
R21 · FY2013 · NS · contact PI
Minocycline to Improve Neurologic Outcome (MINO Clinical Trial)$512,316
R01 · FY2009 · NS · contact PI
Minocycline to Improve Neurologic Outcome (MINO Clinical Trial)$502,980
R01 · FY2008 · NS · contact PI
Minocycline to Improve Neurologic Outcome (MINO Clinical Trial)$575,094
R01 · FY2007 · NS · contact PI
Breaking the Blood-Brain Barrier after Stroke$136,325
R21 · FY2003 · NS
Breaking the Blood-Brain Barrier after Stroke$47,000
R21 · FY2003 · NS
Breaking the Blood-Brain Barrier after Stroke$136,325
R21 · FY2002 · NS